Arca
Skip to content

Acumen Hypotension Prediction Index (HPI) Feature Software

Adjunctive Predictive Cardiovascular Indicator. De Novo DEN160044, from Edwards Lifesciences, LLC (Irvine, CA). Product code QAQ, class 2.

As of Nov 17, 2026, DEN160044 is an FDA De Novo held by Edwards Lifesciences, LLC, granted on Mar 16, 2018 after 536 days, with no recalls tied to it in FDA's recall database.

  • Granted: Mar 16, 2018
  • Review time: 536 days
  • Recalls: 0
  • Cited as a predicate by: 6 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Edwards Lifesciences Acumen Hypotension Prediction Index feature provides the clinician with physiological insight into a patient’s likelihood of future hypotensive events (defined as mean arterial pressure < 65 mmHg for at least one minute in duration) and the associated hemodynamics.

Pivotal Study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Prospective, protocol-collected multicenter clinical validation database of acute care OR patients vs. annotated hypotensive events
Enrolled
52
Primary endpoint
Sensitivity, specificity, and AUC for predicting hypotension (MAP <65 mmHg for at least 1 min) at HPI threshold 85
Result
Sensitivity 83.7% [81.5, 86.0], specificity 99.8% [99.4, 100.0], AUC 0.95 (N=52); no stated performance goal

Cited as a Predicate

6 later 510(k) summaries name this device as a predicate

Other QAQ Clearances

The newest 510(k)s for the same product code; their median review was 265 days; see every QAQ device

Elsewhere

Record

Type
Direct
Received
Sep 26, 2016
Review panel
Cardiovascular
Regulation
21 CFR 870.2210

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.